Sage Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Sage Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sage Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Sage Therapeutics by Citadel Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $5.4M | 744k | 7.22 |
2024-06-30 | $6.6M | 608k | 10.86 |
2024-03-31 | $3.7M | 195k | 18.74 |
2023-12-31 | $12M | 538k | 21.67 |
2023-09-30 | $12M | 566k | 20.58 |
2023-06-30 | $14M | 304k | 47.02 |
2023-03-31 | $4.3M | 101k | 41.96 |
2022-12-31 | $5.8M | 152k | 38.14 |
2022-06-30 | $4.9M | 150k | 32.30 |
2022-03-31 | $9.2M | 278k | 33.10 |
2021-12-31 | $55M | 1.3M | 42.54 |
2021-09-30 | $42M | 942k | 44.31 |
2021-06-30 | $64M | 1.1M | 56.81 |
2021-03-31 | $21M | 275k | 74.85 |
2020-12-31 | $58M | 665k | 86.51 |
2020-09-30 | $99M | 1.6M | 61.12 |
2020-06-30 | $79M | 1.9M | 41.58 |
2020-03-31 | $21M | 746k | 28.72 |
2019-12-31 | $65M | 900k | 72.19 |
2019-09-30 | $54M | 385k | 140.40 |
2019-06-30 | $43M | 234k | 183.02 |
2019-03-31 | $22M | 135k | 159.06 |
2018-12-31 | $25M | 258k | 95.79 |
2018-09-30 | $41M | 292k | 141.25 |
2018-06-30 | $17M | 106k | 156.61 |
2018-03-31 | $20M | 125k | 161.07 |
2017-12-31 | $23M | 140k | 164.70 |
2017-09-30 | $11M | 178k | 62.31 |
2017-06-30 | $6.3M | 80k | 79.67 |
2017-03-31 | $11M | 159k | 71.06 |
2016-12-31 | $5.6M | 109k | 51.06 |
2016-09-30 | $60M | 1.3M | 46.04 |
2016-06-30 | $20M | 650k | 30.13 |
2016-03-31 | $16M | 486k | 32.06 |
2015-12-31 | $14M | 240k | 58.30 |
2015-09-30 | $5.4M | 128k | 42.35 |
2015-03-31 | $656k | 13k | 50.22 |
2014-12-31 | $2.0M | 55k | 36.60 |
2014-09-30 | $1.3M | 41k | 31.50 |